Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon γ-inducible major histocompatibility complex class I expression in chlamydia-infected cells

Journal of Experimental Medicine

Volumn 191, Issue 9, 2000, Pages 1525-1534

  Zhong, Guangming ^a,b   Liu, Li ^a   Fan, Tao ^a   Fan, Peiyi ^a   Ji, Hezhao ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Chlamydial infection; IFN induction; MHC class I suppression; Proteasomal activity; RFX5 degradation

Indexed keywords

GAMMA INTERFERON; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CHLAMYDIA; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; HOST CELL; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS;

BACTERIAL PROTEINS; CELLS, CULTURED; CHLAMYDIA TRACHOMATIS; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION FACTORS;

EID: 0034193165     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.9.1525     Document Type: Article

References (49)

1. Harty, J.T., and M.J. Bevan. 1999. Responses of CD8(+) T cells to intracellular bacteria. Curr. Opin. Immunol. 11:89-93.
2. Bouwer, H.G., R.A. Barry, and D.J. Hinrichs. 1997. Acquired immunity to an intracellular pathogen: immunologic recognition of L. monocytogenes-infected cells. Immunol. Rev. 158:137-146.
3. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
4. Moretta, A. 1997. Molecular mechanisms in cell-mediated cytotoxicity. Cell. 90:13-18.
5. Tascon, R.E., E. Stavropoulos, K.V. Lukacs, and M.J. Colston. 1998. Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect. Immun. 66:830-834.
6. Jones, T.R., L.K. Hanson, L. Sun, J.S. Slater, R.M. Stenberg, and A.E. Campbell. 1995. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:4830-4841.
7. Luder, C.G., T. Lang, B. Beuerle, and U. Gross. 1998. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin. Exp. Immunol. 112: 308-316.
8. Schuller, S., S. Kugler, and W. Goebel. 1998. Suppression of major histocompatibility complex class I and class II gene expression in Listeria monocytogenes-infected murine macrophages. FEMS Immunol. Med. Microbiol. 20:289-299.
9. Reiner, N.E., W. Ng, and W.R. McMaster. 1987. Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J. Immunol. 138:1926-1932.
10. Gobin, S.J., A. Peijnenburg, V. Keijsers, and P.J. van den Elsen. 1997. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:601-611.
11. Gaczynska, M., K.L. Rock, and A.L. Goldberg. 1993. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature. 365:264-267.
12. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J.C. Sanchez, D.F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273-277.
13. van den Elsen, P.J., S.J.P. Gobin, M.C. van Eggermond, and A. Peijnenburg. 1998. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics. 48:208-221.
14. van den Elsen, P.J., A. Peijnenburg, M.C. van Eggermond, and S.J. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today. 19:308-312.
15. Steimle, V., B. Durand, E. Barras, M. Zufferey, M.R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021-1032.
16. Gobin, S.J., A. Peijnenburg, M. van Eggermond, M. van Zutphen, R. van den Berg, and P.J. van den Elsen. 1998. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity. 9:531-541.
17. Lehner, P.J., J.T. Karttunen, G.W. Wilkinson, and P. Cresswell. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA. 94:6904-6909.
18. Hengel, H., T. Flohr, G.J. Hammerling, U.H. Koszinowski, and F. Momburg. 1996. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77:2287-2296.
19. Fruh, K., K. Ahn, and P.A. Peterson. 1997. Inhibition of MHC class I antigen presentation by viral proteins. J. Mol. Med. 75:18-27.
20. Hengel, H., U. Reusch, A. Gutermann, H. Ziegler, S. Jonjic, P. Lucin, and U.H. Koszinowski. 1999. Cytomegaloviral control of MHC class I function in the mouse. Immunol. Rev. 168:167-176.
21. Patton, D.L., M. Askienazy-Elbhar, J. Henry-Suchet, L.A. Campbell, A. Cappuccio, W. Tannous, S.P. Wang, and C.C. Kuo. 1994. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am. J. Obstet. Gynecol. 171:95-101.
22. Cappuccio, A.L., D.L. Patton, C.C. Kuo, and L.A. Campbell. 1994. Detection of Chlamydia trachomatis deoxyribonucleic acid in monkey models (Macaca nemestrina) of salpingitis by in situ hybridization: implications for pathogenesis. Am. J. Obstet. Gynecol. 171:102-110.
23. Zhong, G., T. Fan, and L. Liu. 1999. Chlamydia inhibits interferon γ-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1931-1938.
24. Fan, T., H. Lu, H. Hu, L. Shi, G.A. McClarty, D.M. Nance, A.H. Greenberg, and G. Zhong. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187: 487-496.
25. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengede, P.M. Kloetzel, J. Neefjes, U. Koszinowski, et al. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity. 5:115-124.
26. Bertoletti, A., A. Sette, F.V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells [see comments]. Nature. 369: 407-410.
27. Wiertz, E.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:769-779.
28. Ahn, K., A. Gruhler, B. Galocha, T.R. Jones, E.J. Wiertz, H.L. Ploegh, P.A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:613-621.
29. Cles, L.D., and W.E. Stamm. 1990. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 28:938-940.
30. Zhong, G., F. Castellino, P. Romagnoli, and R.N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:2061-2066.
31. Hendil, K.B., P. Kristensen, and W. Uerkvitz. 1995. Human proteasomes analysed with monoclonal antibodies. Biochem. J. 305:245-252.
32. Scidmore, M.A, E.R. Fischer, and T. Hackstadt. 1996. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J. Cell Biol. 134:363-374.
33. Glas, R., M. Bogyo, J.S. McMaster, M. Gaczynska, and H.L. Ploegh. 1998. A proteolytic system that compensates for loss of proteasome function. Nature. 392:618-622.
34. Geier, E., G. Pfeifer, M. Wilm, M. Lucchiari-Hartz, W. Baumeister, K. Eichmann, and G. Niedermann. 1999. A giant protease with potential to substitute for some functions of the proteasome. Science. 283:978-981.
35. Hendil, K.B., S. Khan, and K. Tanaka. 1998. Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochem. J. 332:749-754.
36. Ward, E.M. 1999. Mechanisms of chlamydia-induced diseases. In Chlamydia: Intracellular Biology, Pathogenesis, and Immunity. R.S. Stephens, editor. ASM Press, Washington, DC. 171-210.
37. Martin, B.K., K.C. Chin, J.C. Olsen, C.A. Skinner, A. Dey, K. Ozato, and J.P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:591-600.
38. Moreno, C.S., E.M. Rogers, J.A. Brown, and J.M. Boss. 1997. Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158:5841-5848.
39. Look, D.C., W.T. Roswit, A.G. Frick, Y. Gris-Alevy, D.M. Dickhaus, M.J. Walter, and M.J. Holtzman. 1998. Direct suppression of Stat1 function during adenoviral infection. Immunity. 9:871-880.
40. Miller, D.M., B.M. Rahill, J.M. Boss, M.D. Lairmore, J.E. Durbin, J.W. Waldman, and D.D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
41. Scidmore, M.A, D.D. Rockey, E.R. Fischer, R.A. Heinzen, and T. Hackstadt. 1996. Vesicular interactions of the Chlamydia trachomatis inclusion ire determined by chlamydial early protein synthesis rather than route of entry. Infect. Immun. 64:5366-5372.
42. Kim, S.K., M. Angevine, K. Demick, L. Ortiz, R. Rudersdorf, D. Watkins, and R. DeMars. 1999. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. J. Immunol. 162:6855-6866.
43. Starnbach, M.N., M.J. Bevan, and M.F. Lampe. 1995. Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect. Immun. 63: 3527-3530.
44. Beatty, P.R., S.J. Rasmussen, and R.S. Stephens. 1997. Cross-reactive cytotoxic T-lymphocyte-mediated lysis of Chlamydia trachomatis- and Chlamydia psittaci-infected cells. Infect. Immun. 65:951-956.
45. Qvigstad, E., and H. Hirschberg. 1984. Lack of cell-mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Pathol. Microbiol. Immunol. Scand. 92:153-159.
46. Pavia, C.S., and J. Schachter. 1983. Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect. Immun. 39:1271-1274.
47. Rasmussen, S.J., L. Eckmann, A.J. Quayle, L. Shen, Y.X. Zhang, D.J. Anderson, J. Fierer, R.S. Stephens, and M.F. Kagnoff. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99:77-87.
48. Morrison, R.P., K. Feilzer, and D.B. Tumas. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4661-4668.
49. Perry, L.L., K. Feilzer, S. Hughes, and H.D. Caldwell. 1999. Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect. Immun. 67:1379-1385.